The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-β-cyclodextrin

被引：51

作者：

Gladys, G ^{[1
]}

Claudia, G ^{[1
]}

Marcela, L ^{[1
]}

机构：

[1] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Farm, RA-5000 Cordoba, Argentina

来源：

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2003年 / 20卷 / 03期

关键词：

multicomponent complex formation; inclusion complex; sulfisoxazole; solubility; thermal analysis; hydroxypropyl-beta-cyclodextrin (HP-beta-CD);

D O I：

10.1016/S0928-0987(03)00202-1

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A novel complexation of sulfisoxazole with hydroxypropyl-beta-cyclodextrin (HP-beta-CD) was studied. Two systems were used: binary complexes prepared with HP-beta-CD and multicomponent system (HP-beta-CD and the basic compound triethanolamine (TEA)). Inclusion complex formation in aqueous solutions and in solid state were investigated by the solubility method, thermal analysis (differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA)), Fourier-transform infrared spectroscopy (FT-IR) and dissolution studies. The solid complexes of sulfisoxazole were prepared by freeze-drying the homogeneous concentrated aqueous solutions in molar ratios of sulfisoxazole:HP-beta-CD 1:1 and 1:2, and sulfisoxazole:TEA:HP-beta-CD 1:1:2. FIF-IR and thermal analysis showed differences among sulfisoxazole:HP-beta-CD and sulfisoxazole:TEA:HP-beta-CD and their corresponding physical mixtures and individual components. The HP-beta-CD solubilization of sulfisoxazole could be improved by ionization of the drug molecule through pH adjustments. However, larger improvements of the HP-beta-CD solubilization are obtained when multicomponent systems are used, allowing to reduce the amount of CD necessary to prepare the target formulation. (C) 2003 Elsevier B.V All rights reserved.

引用

页码：285 / 293

页数：9

共 23 条

[1] Solid-state β-cyclodextrin complexes containing indomethacin, ammonia and water.: II.: Solubility studies [J].

Casella, R ;

Williams, DA ;

Jambhekar, SS .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 165 (01) :15-22

[2] MECHANISM OF DRUG DISSOLUTION RATE ENHANCEMENT FROM BETA-CYCLODEXTRIN-DRUG SYSTEMS [J].

CORRIGAN, OI ;

STANLEY, CT .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (10) :621-626

[3] PREPARATION OF BUFFER SYSTEMS OF CONSTANT IONIC STRENGTH [J].

ELVING, PJ ;

MARKOWITZ, JM ;

ROSENTHAL, I .

ANALYTICAL CHEMISTRY, 1956, 28 (07) :1179-1180

[4] Preparation and evaluation of ketoconazole-beta-cyclodextrin multicomponent complexes [J].

EsclusaDiaz, MT ;

GayoOtero, M ;

PerezMarcos, MB ;

VilaJato, JL ;

TorresLabandeira, JJ .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 142 (02) :183-187

[5] 1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with α-cyclodextrin in the presence of malic acid [J].

Faucci, MT ;

Melani, F ;

Mura, P .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 23 (01) :25-31

[6]

FENYVES E, 1996, P EUR S FORM POORL A, P286

[7]

FENYVESI E, 1994, P 7 INT S CYCL, P414

[8] Study of the inclusion complex of atenolol with β-cyclodextrins [J].

Ficarra, R ;

Ficarra, P ;

Di Bella, MR ;

Raneri, D ;

Tommasini, S ;

Calabrò, ML ;

Villari, A ;

Coppolino, S .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 23 (01) :231-236

[9] FREEZE-DRIED PREPARATIONS OF KETOPROFEN AND HEPTAKIS-(2,6-O-DIMETHYL)-BETA-CYCLODEXTRIN [J].

FUNK, O ;

SCHWABE, L ;

FROMMING, KH .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (12) :1957-1969

[10]

Higuchi T., 1965, Interscience, New York, V4, P117

← 1 2 3 →